Cannell Capital - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Cannell Capital ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$30,976
-3.2%
16,8350.0%0.01%0.0%
Q4 2022$31,987
-11.1%
16,8350.0%0.01%
-25.0%
Q3 2022$36,000
+227.3%
16,835
+320.8%
0.01%
+300.0%
Q2 2022$11,0004,0010.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 2,150,000$34,465,0004.59%
Eversept Partners, LP 258,360$4,141,5110.57%
Alphabet Inc. 698,262$11,193,0000.52%
DAFNA Capital Management LLC 64,235$1,030,0000.30%
Cormorant Asset Management, LP 479,988$7,694,0000.29%
Opaleye Management Inc. 60,000$962,0000.19%
Granahan Investment Management 330,747$5,302,0000.19%
Artal Group S.A. 400,000$6,412,0000.18%
Burrage Capital Management LLC 15,006$241,0000.17%
MPM BioImpact LLC 39,740$637,0000.17%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders